课题基金 / 基金详情

IGF::OT::IGF Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of Ke

IGF::OT::IGF Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of Ke
IGF::OT::IGF 双盲、安慰剂对照、概念验证 (POC) Ke 试验
批准号:
8759330
负责人:
X X
金额:
$300.56万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-12 至 2015-05-11

项目摘要

项目成果

X X的其他基金

相似基金

相关文献

中文摘要
翻译
该计划所需的一般方法是首先建立一个小型临床试验中心团队,然后在充分把握度的人类概念验证试验中测试已确定的干预措施(药理学和/或非药理学)。试验将在团队成员(包括NIMH校内研究计划)确定有希望的干预措施后启动,并由RAPID指导委员会和NIMH合同官员的技术代表(COTR)(有时也称为政府项目官员)批准。 如果根据本合同或在该领域确定的任何化合物/干预措施被证明是有前途的,政府可以选择使用该化合物/干预措施进行更大规模的疗效试验,以代替其他较小的概念验证试验(见任务4和5)。 下文概述的每个任务领域内的所有工作将由合同中更详细概述的任务订单程序控制。这些程序要求NIMH发出任务订单请求,承包商对请求的响应/建议(包括技术方法和预算),以及NIMH对开始任务订单的最终批准。在任务订单获得批准之前,不得产生或报销费用。核定费用总额是一个上限,未经进一步授权不得超过。 本合同的重点和目标是确定和测试针对难治性抑郁症最有希望的干预措施(药物或非药物)。
英文摘要
The general approach required for this initiative will be to first establish a small team of clinical trial sites and subsequently to test identified interventions (pharmacologic and/or non-pharmacologic) in adequately powered Proof of Concept trials in humans. Trials will be initiated after promising interventions are identified by members of the team (including the NIMH Intramural Research Program), and approved by the RAPID steering committee and the NIMH Contracting Officer¿s Technical Representative (COTR) (sometimes also referred to as the Government Program Officer (GPO)). If any compound/intervention identified under this contract or in the field proves to be promising, the Government may choose to conduct a larger efficacy trial with that compound/intervention in lieu of other smaller Proof of Concept trials (see Tasks 4 and 5). All efforts within each task area outlined below will be controlled by task order procedures outlined in more detail in the contract. These procedures require the issuance of a task order request by NIMH, the Contractor¿s response/proposal to a request (including a technical approach and budget), and final NIMH approval to begin the task order. Costs shall not be incurred or reimbursed until a task order has been approved. The approved total cost is a ceiling that cannot be exceeded without further authorization. The emphasis and objective in this contract is to identify and test the most promising interventions for treatment resistant depression (either pharmacologic or non-pharmacologic).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
01-LOGISTICS FOR NEUROLOGICAL EFFECTS AFTER CHEMICAL NERVE AGENT EXPOSURES NIH WORKSHOP BEING HELD 2/26-27/2014 -- CATALOG # : N/A
  • 批准号:
    8951149
  • 项目类别:
  • 资助金额:
    $5.51万
  • 财政年份:
    2014
  • 负责人:
    X X
  • 依托单位:
    --
Development and Maintenance of a Multigenotypic Caloric Restricted Rodent Colony
IGF::OT::IGF Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of LY
  • 批准号:
    8759327
  • 项目类别:
  • 资助金额:
    $323.66万
  • 财政年份:
    2013
  • 负责人:
    X X
  • 依托单位:
MGT SVCS/CONTRACT & PROCUREMENT SUP
  • 批准号:
    8738841
  • 项目类别:
  • 资助金额:
    $634.73万
  • 财政年份:
    2013
  • 负责人:
    X X
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: